QRG Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

QRG Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$246K	Sell	1,291 -24	-2%	-$4.13K	﹤0.01%	1109
2026 Q1	$222K	Buy	+1,315	New	+$225K	﹤0.01%	1064
2025 Q3	–	Sell	-2,437	Closed	-$308K	–	1100
2025 Q2	$308K	Buy	2,437 +123	+5%	+$15.1K	﹤0.01%	956
2025 Q1	$296K	Buy	+2,314	New	+$314K	﹤0.01%	917

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

QRG Capital Management's IBB Position: Q2 2026 in Review

QRG Capital Management reduced its iShares Biotechnology ETF (IBB) stake by 1.8% in Q2 2026, selling an estimated $4.13K and leaving 1,291 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #1109.

QRG Capital Management first reported a position in IBB in Q1 2025 and has held it in 4 quarters since. The position peaked at $308K in Q2 2025. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

QRG Capital Management held 1,291 shares of iShares Biotechnology ETF worth $246K as of Q2 2026.
QRG Capital Management sold 24 iShares Biotechnology ETF shares in Q2 2026, an estimated $4.13K.
iShares Biotechnology ETF made up ﹤0.01% of QRG Capital Management's portfolio in Q2 2026, its #1109 holding.
QRG Capital Management first reported a position in iShares Biotechnology ETF in Q1 2025 and has held it in 4 quarters since.
QRG Capital Management's iShares Biotechnology ETF position peaked at $308K in Q2 2025.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.